11-113323345-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017868.4(TTC12):āc.116T>Cā(p.Leu39Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000576 in 1,612,970 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017868.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TTC12 | NM_017868.4 | c.116T>C | p.Leu39Pro | missense_variant | 3/22 | ENST00000529221.6 | NP_060338.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TTC12 | ENST00000529221.6 | c.116T>C | p.Leu39Pro | missense_variant | 3/22 | 2 | NM_017868.4 | ENSP00000433757 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000391 AC: 98AN: 250324Hom.: 0 AF XY: 0.000414 AC XY: 56AN XY: 135322
GnomAD4 exome AF: 0.000600 AC: 876AN: 1460786Hom.: 0 Cov.: 30 AF XY: 0.000647 AC XY: 470AN XY: 726698
GnomAD4 genome AF: 0.000348 AC: 53AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.000296 AC XY: 22AN XY: 74362
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 29, 2021 | The c.116T>C (p.L39P) alteration is located in exon 3 (coding exon 2) of the TTC12 gene. This alteration results from a T to C substitution at nucleotide position 116, causing the leucine (L) at amino acid position 39 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at